Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study

scholarly article by Lanfranco Pellesi et al published 6 July 2018 in European Journal of Clinical Pharmacology

Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00228-018-2516-3
P698PubMed publication ID29980818

P50authorLanfranco PellesiQ56924399
Simona GuerzoniQ60329163
P2093author name stringLuigi Alberto Pini
Maria Michela Cainazzo
Daniele Vandelli
Federica Palazzoli
Filippo Marchesi
Manuela Licata
Patrizia Verri
P2860cites workCannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activationQ24605572
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsQ24622202
Human cannabinoid pharmacokineticsQ24652736
Cannabinoids for Medical UseQ29391539
The International Classification of Headache Disorders, 3rd edition (beta version)Q29392338
Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrinQ31057113
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft ExcelQ33533523
Trends in fatal motor vehicle crashes before and after marijuana commercialization in ColoradoQ33799020
Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa.Q34181457
Pharmacokinetics and pharmacodynamics of cannabinoidsQ34185013
Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.Q34192001
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trialQ34306281
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinusQ34360054
Isolation of Delta9-THCA-A from hemp and analytical aspects concerning the determination of Delta9-THC in cannabis productsQ34398128
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiolQ34561595
Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea.Q34644572
Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniquesQ35001064
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Q38503842
Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smokingQ38584097
Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse OutcomeQ39660135
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angelesQ46886354
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.Q47587769
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nauseaQ47636194
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic OutcomesQ47809379
Cannabinoids concentration variability in cannabis olive oil galenic preparationsQ48150492
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometryQ49628533
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administratQ50088951
Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.Q55042938
Metabolites of cannabidiol identified in human urineQ68778658
Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and womenQ70157627
Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjectsQ83630498
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomesQ84445086
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectheadacheQ86
medication overuse headacheQ1756659
P304page(s)1427-1436
P577publication date2018-07-06
P1433published inEuropean Journal of Clinical PharmacologyQ1376707
P1476titlePharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study
P478volume74

Reverse relations

Q98164603Plasma concentrations of eleven cannabinoids in cattle following oral administration of industrial hemp (Cannabis sativa)cites workP2860

Search more.